Trial Profile
Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics of Telmisatan 40mg and S-Amlodipine 5mg as a Fixed Dose Combination Tablet Compared With Combination Therapy in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2011
Price :
$35
*
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Levamlodipine; Telmisartan
- Indications Hypertension
- Focus Pharmacokinetics
- 27 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2011 New trial record